There’s a lot of fear around applying artificial intelligence to the life sciences.
And while Diogo Rau concedes that there are risks associated with using AI, the biggest risk is that we won’t use it.
Diogo Rau is EVP and Chief Information and Digital Officer of Eli Lilly & Company, where he leads their information technology, cybersecurity, digital health, advanced analytics and data science functions.
Prior to joining Lilly, Diogo served as Head of Engineering for Apple Retail and Partner at McKinsey & Company.
On this episode of The Beat, Diogo joins host Dr. Gautam Gulati to discuss the use of AI to facilitate clinical trials and drug discovery in a patient-first world.
Diogo explains how he is bringing Apple’s focus on the end user to life sciences, sharing his vision of what an Apple-like healthcare experience looks like and how to create a culture of innovation at Lilly.
Listen in for Diogo’s insight on using tech to inspire behavior change in patients and learn how we might leverage AI to generate new medicines, improve clinical trials and facilitate personalized medicine.
Topics Covered
- How Diogo is bringing Apple’s focus on the end user to life sciences
- Diogo’s take on what differentiates customers from patients
- What inspired Diogo’s transition from Apple to his current role at Lilly
- Leveraging artificial intelligence to facilitate personalized medicine
- Why Lilly is prioritizing AI-designed and generated medicines
- How to discern when we can innovate fast in the life sciences space
- Building a culture of innovation in a large company like Lilly
- How Diogo thinks about Lilly’s role in the healthcare ecosystem
- Diogo’s vision of what an Apple-like healthcare experience looks like
- Using technology to facilitate prevention through behavior change
- Why Lilly is working on both insulin drugs and diabetes prevention
- Diogo’s mission to impact the way medicine gets to patients
Connect with Diogo Rau
Eli Lilly & Company
Diogo on LinkedIn
Connect with Dr. Jessica Shepherd & Dr. Gautam Gulati
HLTH
Dr. Shepherd on X
Dr. Shepherd on LinkedIn
Dr. Gulati on X
Dr. Gulati on LinkedIn
Resources
Clay Christensen’s Model of Disruptive Innovation
Atomic Habits by James Clear
Wait But Why Blog
